Rhumbline Advisers »

Monopar Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $432k 5.3k 81.67
2025-06-30 $209k 5.9k 35.78